{"entity":{"type":"insider","cik":"0001655962","url":"/insider/0001655962","json_url":"/insider/0001655962.json","name":"York Charles N II","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":38,"n_filings":28,"first":"2017-12-05","last":"2026-02-18","span_basis":"filed_date"},"name_variants":[{"name":"York Charles N II","source":"filing","n_filings":28,"first_seen":"2017-12-05","last_seen":"2026-02-18"}],"transactions":[{"id":6174435,"accession":"0001655962-26-000004","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001655962-26-000004","line_url":"/filing/0001655962-26-000004#line-5","is_derivative":false,"issuer_cik":"0001655962","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001655962","owner_cik":"0001655962","owner_name":"York Charles N II","owner_display_name":"York Charles N II","owner_url":"/insider/0001655962","role":"Officer (COO and CFO)","role_mark":"O","role_mark_label":"Officer (COO and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6065.0,"shares_display":"6,065","price_per_share":11.6009,"price_display":"11.60","price_state":"stated","total_value":70359.4585,"total_display":"70,359.46","total_whole":"70,359","shares_owned_after":312025.0,"shares_owned_after_display":"312,025","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-17","filed_date":"2026-02-18","scope":"insider"},{"id":4812095,"accession":"0001655962-25-000006","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001655962-25-000006","line_url":"/filing/0001655962-25-000006#line-5","is_derivative":false,"issuer_cik":"0001655962","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001655962","owner_cik":"0001655962","owner_name":"York Charles N II","owner_display_name":"York Charles N II","owner_url":"/insider/0001655962","role":"Officer (COO and CFO)","role_mark":"O","role_mark_label":"Officer (COO and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4062.0,"shares_display":"4,062","price_per_share":8.9147,"price_display":"8.91","price_state":"stated","total_value":36211.5114,"total_display":"36,211.51","total_whole":"36,212","shares_owned_after":294715.0,"shares_owned_after_display":"294,715","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-17","filed_date":"2025-11-18","scope":"insider"},{"id":5081475,"accession":"0001415889-25-022386","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001415889-25-022386","line_url":"/filing/0001415889-25-022386#line-5","is_derivative":false,"issuer_cik":"0001655962","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001655962","owner_cik":"0001655962","owner_name":"York Charles N II","owner_display_name":"York Charles N II","owner_url":"/insider/0001655962","role":"Officer (COO and CFO)","role_mark":"O","role_mark_label":"Officer (COO and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4106.0,"shares_display":"4,106","price_per_share":6.7671,"price_display":"6.77","price_state":"stated","total_value":27785.7126,"total_display":"27,785.71","total_whole":"27,786","shares_owned_after":278000.0,"shares_owned_after_display":"278,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-18","filed_date":"2025-08-19","scope":"insider"},{"id":4074779,"accession":"0001415889-25-013679","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001415889-25-013679","line_url":"/filing/0001415889-25-013679#line-5","is_derivative":false,"issuer_cik":"0001655962","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001655962","owner_cik":"0001655962","owner_name":"York Charles N II","owner_display_name":"York Charles N II","owner_url":"/insider/0001655962","role":"Officer (COO, CFO AND SECRETARY)","role_mark":"O","role_mark_label":"Officer (COO, CFO AND SECRETARY)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO, CFO AND SECRETARY","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4282.0,"shares_display":"4,282","price_per_share":6.2579,"price_display":"6.26","price_state":"stated","total_value":26796.3278,"total_display":"26,796.33","total_whole":"26,796","shares_owned_after":265231.0,"shares_owned_after_display":"265,231","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-16","filed_date":"2025-05-19","scope":"insider"},{"id":4640225,"accession":"0001415889-25-005159","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001415889-25-005159","line_url":"/filing/0001415889-25-005159#line-5","is_derivative":false,"issuer_cik":"0001655962","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001655962","owner_cik":"0001655962","owner_name":"York Charles N II","owner_display_name":"York Charles N II","owner_url":"/insider/0001655962","role":"Officer (COO, CFO AND SECRETARY)","role_mark":"O","role_mark_label":"Officer (COO, CFO AND SECRETARY)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO, CFO AND SECRETARY","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4370.0,"shares_display":"4,370","price_per_share":11.963,"price_display":"11.96","price_state":"stated","total_value":52278.31,"total_display":"52,278.31","total_whole":"52,278","shares_owned_after":252638.0,"shares_owned_after_display":"252,638","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-18","filed_date":"2025-02-21","scope":"insider"},{"id":2757014,"accession":"0001415889-24-027224","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-027224","line_url":"/filing/0001415889-24-027224#line-4","is_derivative":false,"issuer_cik":"0001655962","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001655962","owner_cik":"0001655962","owner_name":"York Charles N II","owner_display_name":"York Charles N II","owner_url":"/insider/0001655962","role":"Officer (COO, CFO AND SECRETARY)","role_mark":"O","role_mark_label":"Officer (COO, CFO AND SECRETARY)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO, CFO AND SECRETARY","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2602.0,"shares_display":"2,602","price_per_share":13.2102,"price_display":"13.21","price_state":"stated","total_value":34372.9404,"total_display":"34,372.94","total_whole":"34,373","shares_owned_after":240133.0,"shares_owned_after_display":"240,133","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-18","filed_date":"2024-11-19","scope":"insider"},{"id":2156368,"accession":"0001415889-24-021626","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-021626","line_url":"/filing/0001415889-24-021626#line-4","is_derivative":false,"issuer_cik":"0001655962","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001655962","owner_cik":"0001655962","owner_name":"York Charles N II","owner_display_name":"York Charles N II","owner_url":"/insider/0001655962","role":"Officer (COO, CFO AND SECRETARY)","role_mark":"O","role_mark_label":"Officer (COO, CFO AND SECRETARY)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO, CFO AND SECRETARY","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2633.0,"shares_display":"2,633","price_per_share":13.9991,"price_display":"14.00","price_state":"stated","total_value":36859.6303,"total_display":"36,859.63","total_whole":"36,860","shares_owned_after":232485.0,"shares_owned_after_display":"232,485","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-16","filed_date":"2024-08-19","scope":"insider"},{"id":2899686,"accession":"0001415889-24-013616","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-013616","line_url":"/filing/0001415889-24-013616#line-4","is_derivative":false,"issuer_cik":"0001655962","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001655962","owner_cik":"0001655962","owner_name":"York Charles N II","owner_display_name":"York Charles N II","owner_url":"/insider/0001655962","role":"Officer (COO, CFO AND SECRETARY)","role_mark":"O","role_mark_label":"Officer (COO, CFO AND SECRETARY)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO, CFO AND SECRETARY","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2675.0,"shares_display":"2,675","price_per_share":16.0787,"price_display":"16.08","price_state":"stated","total_value":43010.5225,"total_display":"43,010.52","total_whole":"43,011","shares_owned_after":224868.0,"shares_owned_after_display":"224,868","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-16","filed_date":"2024-05-17","scope":"insider"},{"id":2391181,"accession":"0001415889-24-012253","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-012253","line_url":"/filing/0001415889-24-012253#line-3","is_derivative":false,"issuer_cik":"0001655962","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001655962","owner_cik":"0001655962","owner_name":"York Charles N II","owner_display_name":"York Charles N II","owner_url":"/insider/0001655962","role":"Officer (COO, CFO AND SECRETARY)","role_mark":"O","role_mark_label":"Officer (COO, CFO AND SECRETARY)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO, CFO AND SECRETARY","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8078.0,"shares_display":"8,078","price_per_share":17.8527,"price_display":"17.85","price_state":"stated","total_value":144214.1106,"total_display":"144,214.11","total_whole":"144,214","shares_owned_after":217293.0,"shares_owned_after_display":"217,293","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-03","filed_date":"2024-05-03","scope":"insider"},{"id":2391175,"accession":"0001415889-24-012253","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-012253","line_url":"/filing/0001415889-24-012253#line-2","is_derivative":false,"issuer_cik":"0001655962","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001655962","owner_cik":"0001655962","owner_name":"York Charles N II","owner_display_name":"York Charles N II","owner_url":"/insider/0001655962","role":"Officer (COO, CFO AND SECRETARY)","role_mark":"O","role_mark_label":"Officer (COO, CFO AND SECRETARY)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO, CFO AND SECRETARY","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":17.8955,"price_display":"17.90","price_state":"stated","total_value":3579.1,"total_display":"3,579.10","total_whole":"3,579","shares_owned_after":225371.0,"shares_owned_after_display":"225,371","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-02","filed_date":"2024-05-03","scope":"insider"},{"id":2391170,"accession":"0001415889-24-012253","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-012253","line_url":"/filing/0001415889-24-012253#line-1","is_derivative":false,"issuer_cik":"0001655962","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001655962","owner_cik":"0001655962","owner_name":"York Charles N II","owner_display_name":"York Charles N II","owner_url":"/insider/0001655962","role":"Officer (COO, CFO AND SECRETARY)","role_mark":"O","role_mark_label":"Officer (COO, CFO AND SECRETARY)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO, CFO AND SECRETARY","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52183.0,"shares_display":"52,183","price_per_share":17.887,"price_display":"17.89","price_state":"stated","total_value":933397.321,"total_display":"933,397.32","total_whole":"933,397","shares_owned_after":225571.0,"shares_owned_after_display":"225,571","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-01","filed_date":"2024-05-03","scope":"insider"},{"id":2328819,"accession":"0001415889-24-004469","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-004469","line_url":"/filing/0001415889-24-004469#line-4","is_derivative":false,"issuer_cik":"0001655962","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001655962","owner_cik":"0001655962","owner_name":"York Charles N II","owner_display_name":"York Charles N II","owner_url":"/insider/0001655962","role":"Officer (COO, CFO AND SECRETARY)","role_mark":"O","role_mark_label":"Officer (COO, CFO AND SECRETARY)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO, CFO AND SECRETARY","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2666.0,"shares_display":"2,666","price_per_share":15.2481,"price_display":"15.25","price_state":"stated","total_value":40651.4346,"total_display":"40,651.43","total_whole":"40,651","shares_owned_after":277754.0,"shares_owned_after_display":"277,754","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-16","filed_date":"2024-02-20","scope":"insider"},{"id":8405893,"accession":"0001209191-23-055896","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-055896","line_url":"/filing/0001209191-23-055896#line-3","is_derivative":false,"issuer_cik":"0001655962","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001655962","owner_cik":"0001655962","owner_name":"York Charles N II","owner_display_name":"York Charles N II","owner_url":"/insider/0001655962","role":"Officer (COO, CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COO, CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO, CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":956.0,"shares_display":"956","price_per_share":11.69,"price_display":"11.69","price_state":"stated","total_value":11175.64,"total_display":"11,175.64","total_whole":"11,176","shares_owned_after":270170.0,"shares_owned_after_display":"270,170","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-16","filed_date":"2023-11-17","scope":"insider"},{"id":8680647,"accession":"0001209191-23-046430","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-046430","line_url":"/filing/0001209191-23-046430#line-3","is_derivative":false,"issuer_cik":"0001655962","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001655962","owner_cik":"0001655962","owner_name":"York Charles N II","owner_display_name":"York Charles N II","owner_url":"/insider/0001655962","role":"Officer (COO, CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COO, CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO, CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":922.0,"shares_display":"922","price_per_share":13.86,"price_display":"13.86","price_state":"stated","total_value":12778.92,"total_display":"12,778.92","total_whole":"12,779","shares_owned_after":267501.0,"shares_owned_after_display":"267,501","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-17","filed_date":"2023-08-17","scope":"insider"},{"id":8499885,"accession":"0001209191-23-030395","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-030395","line_url":"/filing/0001209191-23-030395#line-3","is_derivative":false,"issuer_cik":"0001655962","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001655962","owner_cik":"0001655962","owner_name":"York Charles N II","owner_display_name":"York Charles N II","owner_url":"/insider/0001655962","role":"Officer (COO, CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COO, CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO, CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":955.0,"shares_display":"955","price_per_share":13.1223,"price_display":"13.12","price_state":"stated","total_value":12531.7965,"total_display":"12,531.80","total_whole":"12,532","shares_owned_after":264798.0,"shares_owned_after_display":"264,798","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-16","filed_date":"2023-05-17","scope":"insider"},{"id":8288177,"accession":"0001209191-23-011263","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-011263","line_url":"/filing/0001209191-23-011263#line-1","is_derivative":false,"issuer_cik":"0001655962","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001655962","owner_cik":"0001655962","owner_name":"York Charles N II","owner_display_name":"York Charles N II","owner_url":"/insider/0001655962","role":"Officer (COO, CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COO, CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO, CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9377.0,"shares_display":"9,377","price_per_share":20.0267,"price_display":"20.03","price_state":"stated","total_value":187790.3659,"total_display":"187,790.37","total_whole":"187,790","shares_owned_after":262128.0,"shares_owned_after_display":"262,128","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-17","filed_date":"2023-02-21","scope":"insider"},{"id":8214404,"accession":"0001209191-23-010823","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-010823","line_url":"/filing/0001209191-23-010823#line-3","is_derivative":false,"issuer_cik":"0001655962","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001655962","owner_cik":"0001655962","owner_name":"York Charles N II","owner_display_name":"York Charles N II","owner_url":"/insider/0001655962","role":"Officer (COO, CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COO, CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO, CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":930.0,"shares_display":"930","price_per_share":19.573,"price_display":"19.57","price_state":"stated","total_value":18202.89,"total_display":"18,202.89","total_whole":"18,203","shares_owned_after":271505.0,"shares_owned_after_display":"271,505","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-16","filed_date":"2023-02-17","scope":"insider"},{"id":8362852,"accession":"0001209191-23-004485","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-004485","line_url":"/filing/0001209191-23-004485#line-1","is_derivative":false,"issuer_cik":"0001655962","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001655962","owner_cik":"0001655962","owner_name":"York Charles N II","owner_display_name":"York Charles N II","owner_url":"/insider/0001655962","role":"Officer (COO, CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COO, CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO, CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":22.7523,"price_display":"22.75","price_state":"stated","total_value":227523.0,"total_display":"227,523.00","total_whole":"227,523","shares_owned_after":268810.0,"shares_owned_after_display":"268,810","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-20","filed_date":"2023-01-23","scope":"insider"},{"id":6498104,"accession":"0001209191-22-062486","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-062486","line_url":"/filing/0001209191-22-062486#line-1","is_derivative":false,"issuer_cik":"0001655962","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001655962","owner_cik":"0001655962","owner_name":"York Charles N II","owner_display_name":"York Charles N II","owner_url":"/insider/0001655962","role":"Officer (COO, CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COO, CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO, CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":20.065,"price_display":"20.06","price_state":"stated","total_value":200650.0,"total_display":"200,650.00","total_whole":"200,650","shares_owned_after":276497.0,"shares_owned_after_display":"276,497","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-20","filed_date":"2022-12-22","scope":"insider"},{"id":6497899,"accession":"0001209191-22-058493","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-058493","line_url":"/filing/0001209191-22-058493","is_derivative":false,"issuer_cik":"0001655962","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001655962","owner_cik":"0001655962","owner_name":"York Charles N II","owner_display_name":"York Charles N II","owner_url":"/insider/0001655962","role":"Officer (COO, CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COO, CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO, CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":20.756978,"price_display":"20.76","price_state":"stated","total_value":207569.78,"total_display":"207,569.78","total_whole":"207,570","shares_owned_after":286797.0,"shares_owned_after_display":"286,797","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-21","filed_date":"2022-11-22","scope":"insider","n_lines":2},{"id":6374911,"accession":"0001209191-22-057645","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-057645","line_url":"/filing/0001209191-22-057645#line-2","is_derivative":false,"issuer_cik":"0001655962","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001655962","owner_cik":"0001655962","owner_name":"York Charles N II","owner_display_name":"York Charles N II","owner_url":"/insider/0001655962","role":"Officer (COO, CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COO, CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO, CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":430.0,"shares_display":"430","price_per_share":21.4598,"price_display":"21.46","price_state":"stated","total_value":9227.714,"total_display":"9,227.71","total_whole":"9,228","shares_owned_after":296497.0,"shares_owned_after_display":"296,497","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-16","filed_date":"2022-11-17","scope":"insider"},{"id":6497775,"accession":"0001209191-22-055609","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-055609","line_url":"/filing/0001209191-22-055609#line-1","is_derivative":false,"issuer_cik":"0001655962","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001655962","owner_cik":"0001655962","owner_name":"York Charles N II","owner_display_name":"York Charles N II","owner_url":"/insider/0001655962","role":"Officer (COO, CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COO, CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO, CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":20.0313,"price_display":"20.03","price_state":"stated","total_value":200313.0,"total_display":"200,313.00","total_whole":"200,313","shares_owned_after":294401.0,"shares_owned_after_display":"294,401","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-01","filed_date":"2022-11-03","scope":"insider"},{"id":6431612,"accession":"0001209191-22-052763","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-052763","line_url":"/filing/0001209191-22-052763#line-1","is_derivative":false,"issuer_cik":"0001655962","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001655962","owner_cik":"0001655962","owner_name":"York Charles N II","owner_display_name":"York Charles N II","owner_url":"/insider/0001655962","role":"Officer (COO, CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COO, CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO, CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":20.0473,"price_display":"20.05","price_state":"stated","total_value":200473.0,"total_display":"200,473.00","total_whole":"200,473","shares_owned_after":304401.0,"shares_owned_after_display":"304,401","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-03","filed_date":"2022-10-05","scope":"insider"},{"id":6672886,"accession":"0001209191-22-048900","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-048900","line_url":"/filing/0001209191-22-048900","is_derivative":false,"issuer_cik":"0001655962","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001655962","owner_cik":"0001655962","owner_name":"York Charles N II","owner_display_name":"York Charles N II","owner_url":"/insider/0001655962","role":"Officer (COO, CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COO, CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO, CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":23.24843236,"price_display":"23.25","price_state":"stated","total_value":232484.3236,"total_display":"232,484.32","total_whole":"232,484","shares_owned_after":315795.0,"shares_owned_after_display":"315,795","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-01","filed_date":"2022-09-06","scope":"insider","n_lines":2},{"id":6574119,"accession":"0001209191-22-046482","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-046482","line_url":"/filing/0001209191-22-046482#line-2","is_derivative":false,"issuer_cik":"0001655962","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001655962","owner_cik":"0001655962","owner_name":"York Charles N II","owner_display_name":"York Charles N II","owner_url":"/insider/0001655962","role":"Officer (COO, CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COO, CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO, CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1089.0,"shares_display":"1,089","price_per_share":24.31,"price_display":"24.31","price_state":"stated","total_value":26473.59,"total_display":"26,473.59","total_whole":"26,474","shares_owned_after":324401.0,"shares_owned_after_display":"324,401","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-16","filed_date":"2022-08-17","scope":"insider"},{"id":6657496,"accession":"0001209191-22-044601","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-044601","line_url":"/filing/0001209191-22-044601#line-1","is_derivative":false,"issuer_cik":"0001655962","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001655962","owner_cik":"0001655962","owner_name":"York Charles N II","owner_display_name":"York Charles N II","owner_url":"/insider/0001655962","role":"Officer (COO, CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COO, CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO, CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":20.0541,"price_display":"20.05","price_state":"stated","total_value":200541.0,"total_display":"200,541.00","total_whole":"200,541","shares_owned_after":321365.0,"shares_owned_after_display":"321,365","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-04","filed_date":"2022-08-05","scope":"insider"},{"id":6352896,"accession":"0001209191-22-042766","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-042766","line_url":"/filing/0001209191-22-042766#line-1","is_derivative":false,"issuer_cik":"0001655962","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001655962","owner_cik":"0001655962","owner_name":"York Charles N II","owner_display_name":"York Charles N II","owner_url":"/insider/0001655962","role":"Officer (COO, CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COO, CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO, CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":50000.0,"total_display":"50,000.00","total_whole":"50,000","shares_owned_after":331365.0,"shares_owned_after_display":"331,365","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-18","filed_date":"2022-07-20","scope":"insider"},{"id":6276998,"accession":"0001209191-22-041977","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-041977","line_url":"/filing/0001209191-22-041977#line-1","is_derivative":false,"issuer_cik":"0001655962","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001655962","owner_cik":"0001655962","owner_name":"York Charles N II","owner_display_name":"York Charles N II","owner_url":"/insider/0001655962","role":"Officer (COO, CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COO, CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO, CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1416.0,"shares_display":"1,416","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":28320.0,"total_display":"28,320.00","total_whole":"28,320","shares_owned_after":333865.0,"shares_owned_after_display":"333,865","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-08","filed_date":"2022-07-12","scope":"insider"},{"id":6456338,"accession":"0001209191-22-041410","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-041410","line_url":"/filing/0001209191-22-041410#line-2","is_derivative":false,"issuer_cik":"0001655962","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001655962","owner_cik":"0001655962","owner_name":"York Charles N II","owner_display_name":"York Charles N II","owner_url":"/insider/0001655962","role":"Officer (COO, CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COO, CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO, CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":16000.0,"total_display":"16,000.00","total_whole":"16,000","shares_owned_after":335281.0,"shares_owned_after_display":"335,281","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-05","filed_date":"2022-07-06","scope":"insider"},{"id":6456336,"accession":"0001209191-22-041410","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-041410","line_url":"/filing/0001209191-22-041410#line-1","is_derivative":false,"issuer_cik":"0001655962","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001655962","owner_cik":"0001655962","owner_name":"York Charles N II","owner_display_name":"York Charles N II","owner_url":"/insider/0001655962","role":"Officer (COO, CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (COO, CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO, CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1479.0,"shares_display":"1,479","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":29580.0,"total_display":"29,580.00","total_whole":"29,580","shares_owned_after":336081.0,"shares_owned_after_display":"336,081","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-01","filed_date":"2022-07-06","scope":"insider"},{"id":4673273,"accession":"0001140361-17-045129","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-17-045129","line_url":"/filing/0001140361-17-045129#line-6","is_derivative":false,"issuer_cik":"0001636282","issuer_name":"Aeglea BioTherapeutics, Inc.","issuer_ticker":"AGLE","issuer_name_source":null,"issuer_url":"/issuer/0001636282","owner_cik":"0001655962","owner_name":"York Charles N II","owner_display_name":"York Charles N II","owner_url":"/insider/0001655962","role":"Officer (Chief Financial Officer and VP)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer and VP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer and VP","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10241.0,"shares_display":"10,241","price_per_share":4.7554,"price_display":"4.76","price_state":"stated","total_value":48700.0514,"total_display":"48,700.05","total_whole":"48,700","shares_owned_after":34787.0,"shares_owned_after_display":"34,787","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-05","filed_date":"2017-12-05","scope":"insider"},{"id":4673270,"accession":"0001140361-17-045129","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001140361-17-045129","line_url":"/filing/0001140361-17-045129#line-5","is_derivative":false,"issuer_cik":"0001636282","issuer_name":"Aeglea BioTherapeutics, Inc.","issuer_ticker":"AGLE","issuer_name_source":null,"issuer_url":"/issuer/0001636282","owner_cik":"0001655962","owner_name":"York Charles N II","owner_display_name":"York Charles N II","owner_url":"/insider/0001655962","role":"Officer (Chief Financial Officer and VP)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer and VP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer and VP","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3259.0,"shares_display":"3,259","price_per_share":4.9699,"price_display":"4.97","price_state":"stated","total_value":16196.9041,"total_display":"16,196.90","total_whole":"16,197","shares_owned_after":24546.0,"shares_owned_after_display":"24,546","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-04","filed_date":"2017-12-05","scope":"insider"},{"id":4673266,"accession":"0001140361-17-045129","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-17-045129","line_url":"/filing/0001140361-17-045129#line-4","is_derivative":false,"issuer_cik":"0001636282","issuer_name":"Aeglea BioTherapeutics, Inc.","issuer_ticker":"AGLE","issuer_name_source":null,"issuer_url":"/issuer/0001636282","owner_cik":"0001655962","owner_name":"York Charles N II","owner_display_name":"York Charles N II","owner_url":"/insider/0001655962","role":"Officer (Chief Financial Officer and VP)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer and VP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer and VP","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6500.0,"shares_display":"6,500","price_per_share":4.5931,"price_display":"4.59","price_state":"stated","total_value":29855.15,"total_display":"29,855.15","total_whole":"29,855","shares_owned_after":21287.0,"shares_owned_after_display":"21,287","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-01","filed_date":"2017-12-05","scope":"insider"},{"id":4673164,"accession":"0001140361-17-045129","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-17-045129","line_url":"/filing/0001140361-17-045129#line-3","is_derivative":false,"issuer_cik":"0001636282","issuer_name":"Aeglea BioTherapeutics, Inc.","issuer_ticker":"AGLE","issuer_name_source":null,"issuer_url":"/issuer/0001636282","owner_cik":"0001655962","owner_name":"York Charles N II","owner_display_name":"York Charles N II","owner_url":"/insider/0001655962","role":"Officer (Chief Financial Officer and VP)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer and VP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer and VP","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1959.0,"shares_display":"1,959","price_per_share":2.516,"price_display":"2.52","price_state":"stated","total_value":4928.844,"total_display":"4,928.84","total_whole":"4,929","shares_owned_after":14787.0,"shares_owned_after_display":"14,787","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-15","filed_date":"2017-12-05","scope":"insider"},{"id":4673158,"accession":"0001140361-17-045129","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-045129","line_url":"/filing/0001140361-17-045129#line-2","is_derivative":false,"issuer_cik":"0001636282","issuer_name":"Aeglea BioTherapeutics, Inc.","issuer_ticker":"AGLE","issuer_name_source":null,"issuer_url":"/issuer/0001636282","owner_cik":"0001655962","owner_name":"York Charles N II","owner_display_name":"York Charles N II","owner_url":"/insider/0001655962","role":"Officer (Chief Financial Officer and VP)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer and VP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer and VP","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":4.284,"price_display":"4.28","price_state":"stated","total_value":8568.0,"total_display":"8,568.00","total_whole":"8,568","shares_owned_after":12828.0,"shares_owned_after_display":"12,828","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-15","filed_date":"2017-12-05","scope":"insider"},{"id":4673151,"accession":"0001140361-17-045129","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-17-045129","line_url":"/filing/0001140361-17-045129#line-1","is_derivative":false,"issuer_cik":"0001636282","issuer_name":"Aeglea BioTherapeutics, Inc.","issuer_ticker":"AGLE","issuer_name_source":null,"issuer_url":"/issuer/0001636282","owner_cik":"0001655962","owner_name":"York Charles N II","owner_display_name":"York Charles N II","owner_url":"/insider/0001655962","role":"Officer (Chief Financial Officer and VP)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer and VP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer and VP","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":3.987,"price_display":"3.99","price_state":"stated","total_value":7974.0,"total_display":"7,974.00","total_whole":"7,974","shares_owned_after":10828.0,"shares_owned_after_display":"10,828","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-15","filed_date":"2017-12-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":38,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":32,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":38},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001845337","name":"Day One Biopharmaceuticals, Inc.","url":"/issuer/0001845337","role":"Officer (COO and CFO)","n_filings":27,"first_seen":"2022-07-06","last_seen":"2026-02-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001636282","name":"Aeglea BioTherapeutics, Inc.","url":"/issuer/0001636282","role":"Officer (Chief Financial Officer and VP)","n_filings":1,"first_seen":"2017-12-05","last_seen":"2017-12-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001655962","retrieved_at":"2026-08-25T18:38:56+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}